Bayer Invests 2.2 Billion in US Pharma Site

Bayer plans to invest 2.2 billion dollars in a new manufacturing site in Ohio to boost its US pharmaceutical revenue. The expansion aims to support key products and create hundreds of new jobs.

Xurve View
Insights:
FILE PHOTO: The logo of Bayer AG is seen in a showroom of the German drugmaker where the annual results news conference takes place in Leverkusen, Germany February 27, 2020.

Bayer AG will invest $2.2B in a new manufacturing site in New Albany, Ohio, targeting a doubling of its United States revenue by the end of the decade. The investment marks a strategic expansion for the Germany-based drugmaker as it scales up its prescription medicine footprint. The expansion aims to capture higher domestic market share despite ongoing pricing pressures from Washington.